Search research articles
Contact Us
Filters
Showing results (171-180 of 192) with videos related to
Page
of 20
Sort By:
Biochemical Pharmacology
|
December 20, 2005
Anti-tumour activity in non-small cell lung cancer models and toxicity profiles for novel ruthenium(II) based organo-metallic compounds
S M Guichard, R Else, E Reid, et al.
International Journal of Cancer
|
March 17, 1997
Intra-tumoral application of a heregulin-exotoxin-a fusion protein causes rapid tumor regression without adverse systemic or local effects
B Groner, B Wick, M Jeschke, et al.
Journal of Natural Products
|
November 20, 2009
Mansouramycins A-D, cytotoxic isoquinolinequinones from a marine streptomycete
Usama W Hawas, Mohamed Shaaban, Khaled A Shaaban, et al.
Investigational New Drugs
|
July 30, 1999
Phase I clinical and pharmacokinetic trial of the podophyllotoxin derivative NK611 administered as intravenous short infusion
I Rassmann, R Thödtmann, M Mross, et al.
Cancer Research
|
May 31, 2002
2-aroylindoles, a novel class of potent, orally active small molecule tubulin inhibitors
Thomas Beckers, Thomas Reissmann, Mathias Schmidt, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
June 20, 2008
Clinical effects of immunotherapy with genetically modified recombinant birch pollen Bet v 1 derivatives
A Purohit, V Niederberger, M Kronqvist, et al.
Bioorganic & Medicinal Chemistry
|
January 13, 2000
Acid-sensitive polyethylene glycol conjugates of doxorubicin: preparation, in vitro efficacy and intracellular distribution
P C Rodrigues, U Beyer, P Schumacher, et al.
Journal of Medicinal Chemistry
|
July 1, 1989
Synthesis, mechanism of action, and biological evaluation of mitosenes
E O Orlemans, W Verboom, M W Scheltinga, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
January 15, 2004
Vaccines for birch pollen allergy based on genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1
V Mahler, S Vrtala, O Kuss, et al.
Anticancer Research
|
July 1, 1992
Morphological and immunocytochemical characteristics of human tumor cell lines for use in a disease-oriented anticancer drug screen
S F Stinson, M C Alley, W C Kopp, et al.
Page
of 20
Search research articles
Search
Showing results (171-180 of 192) with videos related to
Sort By:
Page
of 20
Biochemical Pharmacology
|
December 20, 2005
Anti-tumour activity in non-small cell lung cancer models and toxicity profiles for novel ruthenium(II) based organo-metallic compounds
S M Guichard, R Else, E Reid, et al.
International Journal of Cancer
|
March 17, 1997
Intra-tumoral application of a heregulin-exotoxin-a fusion protein causes rapid tumor regression without adverse systemic or local effects
B Groner, B Wick, M Jeschke, et al.
Journal of Natural Products
|
November 20, 2009
Mansouramycins A-D, cytotoxic isoquinolinequinones from a marine streptomycete
Usama W Hawas, Mohamed Shaaban, Khaled A Shaaban, et al.
Investigational New Drugs
|
July 30, 1999
Phase I clinical and pharmacokinetic trial of the podophyllotoxin derivative NK611 administered as intravenous short infusion
I Rassmann, R Thödtmann, M Mross, et al.
Cancer Research
|
May 31, 2002
2-aroylindoles, a novel class of potent, orally active small molecule tubulin inhibitors
Thomas Beckers, Thomas Reissmann, Mathias Schmidt, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
June 20, 2008
Clinical effects of immunotherapy with genetically modified recombinant birch pollen Bet v 1 derivatives
A Purohit, V Niederberger, M Kronqvist, et al.
Bioorganic & Medicinal Chemistry
|
January 13, 2000
Acid-sensitive polyethylene glycol conjugates of doxorubicin: preparation, in vitro efficacy and intracellular distribution
P C Rodrigues, U Beyer, P Schumacher, et al.
Journal of Medicinal Chemistry
|
July 1, 1989
Synthesis, mechanism of action, and biological evaluation of mitosenes
E O Orlemans, W Verboom, M W Scheltinga, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
January 15, 2004
Vaccines for birch pollen allergy based on genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1
V Mahler, S Vrtala, O Kuss, et al.
Anticancer Research
|
July 1, 1992
Morphological and immunocytochemical characteristics of human tumor cell lines for use in a disease-oriented anticancer drug screen
S F Stinson, M C Alley, W C Kopp, et al.
Page
of 20